Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy
Kieren D Marini, David R Croucher, Rachael A McCloy, Vijesh Vaghjiani, Alvaro Gonzalez-Rajal, Jordan F Hastings, Venessa Chin, Anette Szczepny, Kaja Kostyrko, Cesar Marquez, W Samantha N Jayasekara, Muhammad Alamgeer, Vishal Boolell, Jeremy ZR Han, Todd Waugh, Hong Ching Lee, Samantha R Oakes, Beena Kumar, Craig A Harrison, Mark P Hedger Show all
Science Translational Medicine | AMER ASSOC ADVANCEMENT SCIENCE | Published : 2018
Awarded by Victorian Cancer Agency
Awarded by Cancer Council NSW
Awarded by National Health and Medical Research Council of Australia
This work was supported by the Victorian Cancer Agency (TS10-01), the Cancer Council NSW (RG15-20), the St. Vincent's Clinic Foundation, the Hudson Institute of Medical Research, Paranta Biosciences Limited, the National Health and Medical Research Council of Australia (GNT100120 and GNT546107), the Petre Foundation, and the Victorian Government' Operational Infrastructure Support Program. The contents of this manuscript are solely the responsibility of the participating institutions and individual authors and do not reflect the views of these funding agencies.